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Gastro retentive drug delivery system is one of the approaches to achieve controlled drug delivery. The gastro retentive 
drug delivery system is a way to prolong residence time of active pharmaceutical ingredient in gastrointestinal tract. It 
is also applied for targeting drug in upper gastrointestinal tract for generating local and systemic effect. Controlled 
drug delivery creates a window of absorption that release drug for a longer duration of time before reaching absorp-
tion site. Gastro retentive drug delivery systems have gained wide variation of oral drug distribution in the area of late. 
It includes all the approaches that keep the dosage form in the stomach for a longer duration of time. This also enables 
sustained release of active pharmaceutical ingredient which in turn overcomes many limitations of conventional drug 
delivery systems. It has begun tremendous advances in the field of gastro-retention to meet controlled release of drugs. 
Aim of research. The main aim of this survey to prolong the gastric retention dosage form in the stomach and improve 
the medication concentration in the stomach.  
Material and Method. To prepare this manuscript, various keywords were searched in different search engines such as 
Google, Yahoo, Bing etc. The available information in public domain was collected and classified according to delivery 
system. This review paper aim to provide complete information about different delivery systems related to Gastro reten-
tive drug delivery systems (GRDDS). It is also applied for targeting drug in upper gastrointestinal tract for generating 
local and systemic effect. 
Result. After going through various literatures, it can be said that the GRDDS can improve local bioavailability and 
therapeutic efficacy and dosing frequency possible reduction in dose size. This paper is focused on various physiologi-
cal contemplation and obtainable formulation approaches for development of gastro retentive drug delivery system. 
Conclusions. This article discusses various types of GRDDS and their approaches. The gastric retentive drug delivery 
systems improve drug absorption. Prolonged gastric retention time of therapeutic mutations provide several benefits 
such as improving absorption, bioavailability and enhance the therapeutic action of drug 
Keywords: gastric emptying, gastro retentive drug delivery system (GRDSs), floating drug delivery system, biomucoad-
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1. Introduction 
Floating drug delivery system is also popularly 
known by the name of hydro dynamically controlled 
system. Basically the floating dosage form is of very low 
density, which enable drug to float in gastric media in 
stomach this results in increasing the residence time of 
drug in stomach without affecting gastric emptying rate 
in whole. The dosage form keep floating on gastric con-
tent and release drug in slow manner at desired rate, 
resulting in increased gastric retentive time in the stom-
ach. It also helps in reducing the drug concentration 
variation in plasma. In spite of having many advantages, 
this dosage form suffers number of disadvantages such as 
unpredictable gastric emptying – time, variation of gas-
tric emptying time from person to person, small gastro-
intestinal transit time (8–12 h), and number of drugs have 
absorption windows in upper part of small intestine [1]. 
The formulation scientists have to take care of these 
many number of challenges while designing a gastro 
retentive drug delivery systems. Apart from this the main 
challenge that one face is of shorter gastric residence 
time (GIT), which is unpredictable and changes depend-
ing on number of factors. To be able to design GRDDS 
in a better way, a thorough knowledge and understanding 
of anatomy and physiology of GIT is necessary [2]. Gas-
tric emptying states were fed along with fasting. The 
available literature shows that orally administered con-
trolled drug delivery systems suffer from two major 
challenges low gastric residence time (GRT) and un-
certain GRT [3]. Drugs with solubility in high alkaline 
PH of intestine, can be delivered using gastro retentive 
drug delivery systems. Gastro retentive drug delivery 
system is reported to have increased the solubility of 
such drugs [4]. GRDDS is also used for drugs that 
degrade in colonic region. It is also beneficial for: 
– Improving bioavailability of drug increasing 
therapeutic efficiency of drug. 
– Reducing dose of drug. 
– Maintaining uniform concentration of blood [5]. 
– Reducing fluctuation in therapeutic concentra-
tion of drug. 
2. Importance of GRDDS in the field of phar-
maceuticals 
Immediate release oral delivery systems is most 
widely used to treat disease, there are absorbed at specif-
ic site only. Number of disadvantage of immediate re-
lease dosage form makes it necessary to develop gastro-
retentive drug delivery systems. These systems will help 
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in keeping drug at specific site for longer duration of 
time.  
This is achieved by maintaining the dosage form 
in the stomach and drug is being released at specific 
location in stomach, duodenum and intestine in con-
trolled action. The below structure (Fig. 1) are shown in 
various parts of human stomach [6]. 
 
 
3. GRDD system advantages 
Gastro retentive drug delivery systems having 
various type of benefits in several areas, they are 
following: 
1. It improves drug delivery and drug absorption  
2. By this method controlled amount of drug can 
be delivered [7] 
3. It has a local action on stomach [8] 
4. It minimizes the mucosal irritation 
5. Increases first pass biotransformation 
6. Ease of administration and improved patient 
compliance 
7. Low frequency of dosing 
8. Improves therapeutic efficacy [5] 
9. Sustained release dosage form helps in avoid-
ing gastric irritation [9]. 
GRDDS shows some sort of disadvantages: 
Following are the disadvantages of gastro reten-
tive drug delivery system: 
– Floating drug delivery systems require high  
fluid level in stomach to float and work effectively [1] 
– Drugs that absorb selectively in colon,  
e.g. corticosteroids [1] 
– Drugs that have very limited acid solubility  
(e.g. phenytoin) 
– The drug that undergoes a significant first pass 
metabolism (e.g. nifedipine) 
– The needs for high levels of abdominal fluids for 
the delivery system to float and function efficiently [10] 
– The presence of food is required to delay gastric 
emptying [11] 
Factor affecting of GRDDS 
The factors that affect the gastro retentive system 
for the gastric retention time of dosage forms are: 
Shape and size of dosage form 
– The average gastric residence time of non-
floating dosage forms is highly variable and depends on 
their size, which may be large, medium and small units. 
– Most sizes should be more than 7.5 mm in di-
ameter [12, 13]. 
Density of dosage form 
– Low density dosage form can float 
at the surface of gastric content. High densi-
ty dosage form sinks and remains at bottom 
of stomach. Density of dosage form should 
be less than 1.0gm/cm3 to make the float at 
the surface of gastric content [14]. 
Age 
– GRT is higher in chorion patients 
and lower in newborn and children. Age 
above 70 (>70) now displays GRT [15]. 
Posture 
– GRT may vary between supine and 
conscientious ambulance states [16].  
Gender 
– Males have higher GRT than fe-
males [16]. 
Nature of the meal 
– Meal with high amount of fatty 
acid reduces the gastric retention time. 
This happens due to changes in gastric 
motility [17].  
Frequency of food ingestion 
– When food is ingested frequency, GRT increase 
subsequently. This happens due to low frequency of 
migrating myoelectric cycle [1]. 
 
4. Other drawbacks associated with specific 
type of GRDDS given are [18] 
High density system: this technology find very 
difficult to deliver large amount of drug at specific site. 
Moreover, this systems is not get accepted by pharma-
ceutical industry. This may be the reason due to which 
these type of systems are yet not available in market.  
Floating system: the amount of gastric content is 
one of the most important literature for floating systems. 
Level of fluid is also one of the important factor for float-
ing fluid level must be high for making dosage form float 
at surface [19, 20]. 
Expandable system: these are dosage form 
which comes in contact of gastric fluid expands and 
remain there for a longer duration of time. However, 
these dosage forms have certain limitation. Blocking of 
gastric passage is one of them. They are difficult to man-
ufacture and are not economical. Storage of the dosage 
forms are also challenging due to presence of hydrolysa-
ble and bio degradable polymers [21]. 
Mucoadhesive system and bioadhesive system: 
Epithelial cell are renewed continuously after mucoad-
hesive and bioadhesive dosage form detached from mu-
cosa. Rapid turnover can get of mucus and peristaltic 
movement of stomach cause this detachment [22, 23]. 
Magnetic system: attainment of patient compli-
ance is a major challenge for this type of dosage form. 
 
 
Fig. 1. Various parts of human stomach 




5. Strategies for delaying drug transit through 
GIT: 
Physiological system. It uses natural ingredients 
or fat derivatives such as tri ethanolamine myristate, 
which stimulate duodenal or jejunal receptors to gastric 
emptying [1, 24]. 
 
Pharmaceutical system. 
First two approaches are not used due to toxicity 
problems. The various pharmaceutical approaches are: 
Gastro retentive dosage form. 
The dosage forms that can be maintained in the 
stomach are called GRDF. Over the last two decades, 
numerous of GRDF have been designed to prolong gas-
tric residence time. The below Table 1 shown are transit 
time of dosage form across the GIT [25]. 
 
Table 1 
Transit time of dosage form across the GIT 
No. Dosage form Small intestine Stomach Total transit time (hour) 
1. Tablet 3.1±0.4 2.7±1.5 5.8 
2. Capsule 3.2±0.8 0.8±1.2 4.0 
3. Pellets 3.4±0.1 1.2±1.3 4.6 
4. Solution 4.1±0.5 0.3±0.1 4.4 
 
6. Type of gastro retentive dosage forms and 
approaches: 
Floating system: 
Floating drug delivery system (FDDS) 
Floating drug delivery systems are believed to 
have lower density than gastric contents. This enables 
them to float on the gastric content.  
Effervescent system  
Non effervescent system: 
– Alginate beads  
– Hydrodynamically balanced system  
– Microporous compartment  
– Microbaloons or hollow microspheres [18]. 
 
Floating drug delivery system: 
Floating drug delivery systems utilizes following 
two systems to float at the surface of gastric content: 
– Effervescent system; 
– Non effervescent system. 
Effervescent system and non effervescent system 
of intra-gastric floating drug delivery devices are shown 
in Fig. 2 [24, 26]. 
 
 
Fig. 2. Graphical representation of intra-gastric floating 
drug delivery device 
 
6.1. Effervescent floating system 
Swellable polymers and various effervescent 
forming chemicals are used for formulating this kind of 
systems. They are planned so that when in contact with 
the acidic gastric substance, CO2 is freed and gets entan-
gled in swollen hydrocolloids, which gives lightness to 
the measurement dosage forms [27]. Floatation of 
drug delivery system in the stomach loaded up with 
vacuum, air, or an inert gas [28, 29]. Gas can be 
brought into the floating chamber by the volatilization 
of a natural dissolvable (organic solvent) (e.g., ether 
or cyclopentane) or by the CO2 delivered because of a 
floating responses between organic acids and car-
bonate–bicarbonate salts [30, 31]. These devices con-
tain a hollow deformable unit that changes over from a 
fallen to an extended position and comes back to the 
crumbled position after a pre decided measure of time 
to allow the unconstrained discharge of thin floatable 
system from the stomach [4]. Proportion of sodium 
carbonate and citric acid should ideally be 1:0.76 for 
optimum gas production [18]. 
 
6.2 Non effervescent floating system 
These systems uses higher amount of one of more 
gels (20–75 %) and highly swellable cellulosic hydrocol-
loids. Few extensively used cellulosic hydrocolloids are 
hydroxyethyl cellulose, hydroxylpropyl methylcellulose, 
hydroxypropyl cellulose, sodium carboxymethyl cellu-
lose [32]. Polysaccharides or matrix forming polymers 
are also used for preparing and are incorporated into 
tablets and capsules. Few examples of such compounds 
are polyacrylates, polycarbophil, and polystyrene [33]. 
One these systems are exposed in gastric fluid, these gels 
are hydrated. These hydrated gels along with other poly-
mers form a colloidal gel barrier [34, 35]. These barriers 
thus formed, controls fluid penetration into the system 
and thereby control the release of drug from the systems 
[28, 36, 37]. The following approaches are used to design 
in the intra-gastric floating systems [4]. 
Alginate beads 
These are dosage forms are prepared by freeze 
drying of calcium alginate. Spherical beads are prepared 
by dropping sodium alginate solution into aqueous solu-
tion of calcium chloride [38]. This causes precipitation of 
calcium alginate. The calcium alginate beads were com-
pared to solid beads [39, 40]. It was observed that the 
beads were prolonging residence time. The GRT in the 
case of solid beads was found to be 1 hour whereas with 
calcium alginate beads, GRT of 5.5 hour was observed 
[18, 41]. 
Hydrodynamically balanced intragastric deliv-
ery system (HBS) 
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Hydrodynamically adjusted gastrointestinal drug 
delivery system, either in the form of capsules or tablets, 
they are intended to prolonged gastrointestinal time in a 
zone of the GI tract to maximize the drug, increasing the 
absorption site in arrangement state and subsequently, 
prepared for ingestion [42]. These system are contains to 
drug with gel-forming hydrocolloids intended to stay 
light on the stomach content [5, 43]. This type of systems 
utilizes one or more hydrophilic polymers such as hydro-
philic polymers are - hydroxypropyl methylcellulose 
(HPMC), hydroxethyl cellulose (HEC), hydroxypropyl 
cellulose (HPC), sodium carboxymethyl cellulose 
(NaCMC), polycarbophil. The representation of hydro-
dynamically balanced intragastric delivery are explain in 
figure 3 [44, 45]. 
 
 
Fig. 3. Representation of hydrodynamically balanced 
intragastric delivery system (HBS) 
 
Microporous compartment 
In this type of systems, drug is kept into a micro 
compartment with pores on top and bottom walls, and pe-
ripheral wall is completely sealed. This sealing prevents 
contact of gastric surface and drug reservoir [46, 47]. 
When these systems are administered, air gels get 
entrapped in flotation chamber. This enables delivery 
systems to float on gastric content. Gastric fluids, 
through the pores enter into the systems. The drug gels 
dissolved is the fluid and transport continuously into the 
intestine for absorption [48]. 
Microbaloons or hollow microspheres 
Micro balloons or hollow microspheres are filled 
with drugs in their other polymer layer. Solvent evapora-
tion and solvent diffusion methods used for utilizing 
polymer were used for preparing microbaloons or hallow 
microspheres [46]. Few polymers that are utilized for 
preparing such systems are polycarbonate, cellulose 
acetate, calcium alginate, Eudragit S, etc. [39, 49, 50]. 
The such systems developed floats uniformly on the 
surface of gastric content for more than 12 hours. Hollow 
microspheres are considered to be one of the most prom-
ising floating systems as they are combined with the 
advantages of multi-unit and float much [6]. 
Non-floating system 
This type of system are retained is stomach with 
number of mechanisms. Other than, floating of delivery. 
These systems are maintained in the stomach by many 
mechanisms but not by floating [51, 52]. Non-floating 
system are further subdivided: 
a) Sinking (High density) drug delivery system  
b) Bioadhsive / mucoadhesive system  
c) Magnetic system  
d) Unfoldable system [53]. 
 
Bio adhesive & mucoadhesive system 
The bio adhesive and mucoadhesive system are 
drug delivery systems. They are used as a delivery device 
within the lumen to increasing the absorption of drug into 
a site of specific method [54].  
The bioadhesive system adheres to the epithelial 
cell surface or mucus in stomach. These is done with the 
help of polymers which have mucoadhesive properties. 
Bioadhesive system increase the affinity and time dura-
tion of adhesion between the dosage form and biological 
membrane [55, 56]. Bioadhesive delivery system is also 
reported to have increased bioavailability [57]. The mu-
coadhesive drug delivery systems consist of a mucoad-
hesive polymers, which adheres to the gastric mucosal 
surface and prolong its gastric retention in the GIT [58, 
59]. The mucus creates the ability to adhere to the gel 
layer. These polymers can be natural such as sodium 
alginate, gelatin, guar gum, etc., or semisynthetic poly-
mers such as HPMC, carbopol, sodium carboxy methyl 
cellulose [5, 6, 9]. There are number of natural occurring 
mucilages which are reported to have mucoadhesive 
properties [60, 61]. These mucilages were studied for 
checking their ability to formulate various dosage form 
and reported accordingly in literatures [62–64].  
Hydration-mediated adhesion 
Some polymers are hydrophilic in nature causing 
large amount of water to disperse and become viscous, 
leading to bio-adhesive. Prolonged gastro-retention of the 
bio and muco-adhesive drug delivery system is con-
trolled by the dissolution rate of the polymer [22].  
Bonding-mediated adhesion 
This type adhesion, the polymers used in system 
enables adhesion of system to mucus or epithelial cell 
surface. This type of binding includes various mecha-
nisms which include physical, chemical and mechanical 
binding. Physical or mechanical bonding that may result 
from deposition and inclusion of the adhesive material 
into the crevices of the mucosa [65, 66]. Chemical bonds 
may be either covalent or ionic nature [6, 67]. 
Receptor-mediated adhesion 
Receptor-mediated adhesion polymers are those 
that have the ability to bind specific receptor sites on the 
cell surface. Receptor mediated events act as a potential 
variant in bio and muco-adhesion, therefore enhance 
gastric retention of dosage forms [6]. 
Swelling /Expanding system 
Subsequent to being gulped, these dosage forms 
swell to a size that keeps away from their entrance 
through the pylorus [33]. In this method, as a result, the 
dosage form is maintained in the stomach for a long time. 
These systems are at some point referred for plug point 
system. As a rule, they will stay halted at the pyloric 
sphincter [68]. These polymeric cross sections remain in 
the gastric gloom for a couple of hours even in the few 
worked state. Proceeded and controlled drug release may 
be accomplished by selecting a polymer with the right 
sub-atomic weight and swelling properties [4, 69]. When 
exposed to gastric fluid, the polymer swallows water and 
becomes swollen. The broad swelling of these polymers 
is an after effect of the presence of physical-chemical 




cross links in the hydrophilic polymer organize [70, 71]. 
These cross linking of polymers maintain the physical 
integrity of dosage form and thus retard the rate of disso-
lution [72]. The degree of cross linking between the 
polymeric chin decides the extent and duration of swell-
ing. High degree of cross linking results is maintenance 
of physical integrity of dosage form for a longer period 
of time [73]. This also retards the swelling of the dosage 
form. Low level of cross linking results in faster dissolu-
tion of polymer and at the same time, the dosage form 
swelling capacity is increased [74]. Therefore, a balance 
between the swelling and dissolution is always sought for 
better formulation development. Figure 4 explains a 
relationship between degree of cross linking and swelling 
behaviour dosage form and figure 5 is shown swellable 
system of drug [75, 35]. 
 
 
Fig. 4. Relationship between the degree of cross-linking of the polymeric chains and the swelling behaviour  
of swelling system 
 
 
Fig. 5. Swellable system of drug 
 
6.3. Expandable system 
Expandable systems have initiated to be designed 
from last 3 decades.  
The expanded form that the stomach received and 
inhibits the pathway and finally another short form that 
the stomach received, when retention is no longer need-
ed, i.e. after the GRDF releases its active ingredient [25], 
the expandable dosage form is administered to the stom-
ach and it inhibits the pathway. In the mean time, this 
expandable delivery system release small delivery sys-
tem, when no further retention is needed [76]. This small 
delivery then releases its active ingredients. These gas-
tro-retentive dosage forms GRDFs are swallowed easily 
[77]. This reaches stomach and, wells considerably and is 
retained [37, 78]. These only for a longer duration of 
time with each release of active ingredient, their size 
reduce continuously [21, 79].  
 
Magnetic system 
Magnetic field is the driving force of this type of 
system. In this type of system, a small magnet is placed 
inside the dosage form. Another magnet is placed on the 
abdomen. By using the external magnet, dosage form are 
made to reside at GIT. By this way gastric residence time 
is increased in this type of system [9, 34, 80].  
Superporous hydrogel 
Superporous hydrogel are swellable systems, the-
se are differ adequately from the conventional types to 
justify separate and classification. With pore sizes be-
tween 10 nm to 10 μm, the absorption of water by con-
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ventional hydrogels to reach equilibrium state during 
which early withdrawal can occur in h dosage form. 
Superporous hydrogels, average orifice size > 100 μm, 
and due to rapid watering by capillary wetting through 
swell, abundant open pores to create equilibrium with in 
one minute [81]. These dosage forms swell to form a 
larger size and have sufficient mechanical strength to 
withstand pressure of gastric contraction [25, 82]. 
Raft technology  
The raft technology have established much con-
sideration for the delivery of drug delivery for gastroin-
testinal disorders and infections. A meaning of raft is a 
flat structure, typically made of planks, logs that floats on 
water and is used for transport or as a platform for 
swimmers. This raft floats on gastric fluids due to low 
bulk density developed by the preparation of carbon 
dioxide. Usually, the raft technology have a gel forming 
agent and alkaline bicarbonates or carbonates responsible 
for the formation of CO2 to make the system less dense 
and float on the gastric fluids [83].  
Frame tablets (or tablets with an insoluble skele-
ton) – for their production, auxiliary substances are used 
that form a network structure (matrix), in which the drug 
is included.  
 
7. In – vivo studies literatures 
There are number of literatures which reports in–
vivo studies of gastro–retentive drug delivery system. 




In vivo study of gastro retentive drug delivery system 
Animal Drug 
Rout of drug 
administration 











Oral Solid dispersion 10mg/kg [85] 
Male rats amoxicillin Oral 
mucoadhesive 
microspheres 






0.341 ± 0.110 to 0.717 




ofloxacin Oral Floating pellets 100 mg [87] 
Albino rats pentoxifylline Oral Floating tablet 30±1 mg [88] 
Wistar rats metronidazole Oral 
Muco adhesive 
floating tablet 
















tablet & capsules 
(75 mg per capsule & 




According to various published literature and de-
tailed investigations on viable products, it can be con-
cluded that the gastro-retentive drug delivery systems 
includes advancement, needs and their approaches. 
Gastro-retentive drug delivery system is an approach to 
keep drug at specific site of GIT for longer duration of 
time and target the drug in upper GIT. Issue of drug 
solubility can be also be addressed by developing gastro 
retentive drug delivery system as it allows dosage form 
to reside at absorption site for a longer period. Gastric 
retentive drug delivery systems improve drug absorp-
tion. Prolonged gastric retention time of therapeutic 
mutations provide several benefits such as improving 
absorption, bioavailability and enhance the therapeutic 
action of drug.  
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